coronavirus vaccine candidate developed by Chinese state-owned pharmaceutical company Sinopharm could be ready ahead of previous expectations.
It could be available for public use by the end of this year, Reuters reported, citing state media. Sinopharm had said in June the vaccine shot may not be ready until at least 2021 as a lack of new infections in China made it difficult to find people to test it on.But since then China has since found alternative trial sites abroad in the global race to produce a vaccine to fight a pandemic that has killed over 6 lakh people globally.Sinopharm Chairman Liu Jingzhen told state broadcaster CCTV the company expects to finish late-stage human testing within about three months, Reuters reported.